See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no specific recommended time gap between receiving the cosentyx (secukinumab) medication and being vaccinated. However, it is generally recommended to consult with a healthcare provider for personalized advice regarding vaccinations while on any medication [1].

The Cosentyx prescribing information does not mention any specific time gap between administering the medication and receiving vaccines [2]. Additionally, the Centers for Disease Control and Prevention (CDC) does not list Cosentyx as a medication that requires a specific time gap before or after vaccination [3].

It is important to note that the immune response to vaccines may be reduced in patients receiving immunosuppressive therapy, such as Cosentyx [4]. Therefore, it is crucial to consult with a healthcare provider to discuss the potential impact of Cosentyx on vaccine effectiveness and the need for additional vaccine doses.

In summary, there is no specific recommended time gap between receiving Cosentyx and being vaccinated. However, it is always best to consult with a healthcare provider for personalized advice regarding vaccinations while on any medication.

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
2. Centers for Disease Control and Prevention. General Best Practices for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html>.
3. DrugPatentWatch. Secukinumab (Cosentyx). <https://www.drugpatentwatch.com/drugs/secukinumab>.
4. Wolfe F, Michaud K. Psoriasis and Associated Comorbidities. Clinics in Dermatology. 2007;25(5):445-452. doi:10.1016/j.clindermatol.2007.06.013.